A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pazopanib Impurity 33 - Request Quote

Picture of Pazopanib Impurity 33

Pazopanib Impurity 33

SZ CAT No:SZ-P013049
CAS No
NA
Mol.F.
C27H26N10O
Mol.Wt.
506.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Pazopanib Impurity 33 is chemically N2-(2,3-dimethyl-2H-indazol-6-yl)-N2-(2-methoxypyrimidin-4-yl)-N4-methyl-N4-(2-methyl-2H-indazol-5-yl)pyrimidine-2,4-diamine. Pazopanib Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Pazopanib Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pazopanib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Pazopanib Impurity 33

Purchase Pazopanib Impurity 33

Pazopanib Impurity 33 suppliers

Pazopanib Impurity 33 manufacturers

Pazopanib Impurity 33 price

Order Pazopanib Impurity 33

Enquire Pazopanib Impurity 33

Pazopanib Impurity 33 cost

Pazopanib Impurity 33 Supplier

Pazopanib Impurity 33 Distributor

Pazopanib Impurity 33 for Method Validation

Pazopanib Reference Standard

Pazopanib Impurity 33 for ANDA Filing

Pazopanib Impurity 33 for Forced Degradation Studies

Pazopanib Impurity 33 Identification Standards

Pazopanib Impurity 33 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,